Lisa Cherbuin obtained her Master in medical biology in February 2016 at the University of Lausanne. Her master thesis focuses on the “Rational design of small molecule inhibitors targeting the AKAP-Lbc/RhoA complex as potential anti-cancer agents”.  She really likes all kind of sport and practices volleyball. She will work as laborantine in the group of Liliane Michalik till end of October 2016.